MDNA Life Sciences Inc. (MDLS)
MDNA Life Sciences will go public soon, but the exact IPO date is still unknown.
IPO Price Range
$5.00 - $6.00
Shares Offered
2,454,545
Deal Size
$13.50M
MDNA Life Sciences Revenue
In the fiscal year ending September 30, 2021, MDNA Life Sciences had annual revenue of $3.60M with 3,298.10% growth.
Revenue (ttm)
$3.60M
Revenue Growth
+3,298.10%
P/S Ratio
14.42
Revenue / Employee
$240,153
Employees
15
Market Cap
51.95M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Sep 30, 2021 | 3.60M | 3.50M | 3,298.10% |
| Sep 30, 2020 | 106.01K | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionMDLS News
- 2 years ago - IPO Update: MDNA Life Sciences Readies $10 Million IPO - Seeking Alpha
- 2 years ago - US IPO Weekly Recap: August Kicks off with a 2 IPO week - Renaissance Capital
- 2 years ago - MDNA Life Sciences IPO Registration Document (S-1) - SEC